CHEYENNE , Wyo., June 12, 2024 /PRNewswire/ -- AxonDAO (Axon DAO LLC, Wyoming ) proudly announces the launch of A+Voice, an innovative research platform designed to monitor vocal biomarkers. This platform is an exceptionally effective tool for the early detection and ongoing assessment of conditions such as Alzheimer's, Parkinson's, dementia, post-traumatic stress disorder (PTSD), and Huntington's Disease.
Assessing vocal biomarkers can also evaluate fatigue and energy levels, which could help standardize safety monitoring within a range of professions, such as operators of commercial trucks, cars, and heavy machinery. Looking ahead, AxonDAO plans to enhance their models to also identify biomarkers that evaluate changes in anxiety, stress, and mood. By using decentralized ledger technology, zero-knowledge security, and other advanced technologies, AxonDAO allows research participants to access, own, and control their health data.
Through community engagement and transparent data collection, AxonDAO facilitates research studies on a scale larger than conventional approaches, whether conducted by academia or industry. Introducing A+Voice A+Voice is AxonDAO's groundbreaking biometric AI voice collection and analysis software. The platform utilizes a reward system to collect high-quality, consistent voice data that runs through a quality assessment and analytical engine.
By utilizing blockchain technology, A+Voice timestamps, anonymizes, and processes this data into patterned AI .
